VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195 | -10.6% | 44,389 | 0.0% | 0.25% | -11.2% |
| Q2 2023 | $1,337 | -7.0% | 44,389 | -0.2% | 0.28% | -13.1% |
| Q1 2023 | $1,438 | +11.6% | 44,457 | -1.1% | 0.32% | +15.5% |
| Q4 2022 | $1,289 | -99.9% | 44,970 | +0.9% | 0.28% | -0.4% |
| Q3 2022 | $1,075,000 | -14.3% | 44,559 | -2.7% | 0.28% | -9.2% |
| Q2 2022 | $1,254,000 | -29.6% | 45,794 | -1.5% | 0.31% | -20.3% |
| Q1 2022 | $1,782,000 | +19.5% | 46,479 | -0.2% | 0.38% | +20.4% |
| Q4 2021 | $1,491,000 | +8.7% | 46,564 | 0.0% | 0.32% | +0.6% |
| Q3 2021 | $1,372,000 | -29.0% | 46,564 | -5.7% | 0.32% | -45.1% |
| Q2 2021 | $1,933,000 | +22.8% | 49,364 | +1.9% | 0.58% | +58.5% |
| Q1 2021 | $1,574,000 | -11.9% | 48,444 | -2.3% | 0.36% | -18.0% |
| Q4 2020 | $1,786,000 | -7.6% | 49,584 | +0.4% | 0.44% | -23.1% |
| Q3 2020 | $1,933,000 | +5.9% | 49,364 | -0.9% | 0.58% | -0.2% |
| Q2 2020 | $1,826,000 | +55.1% | 49,792 | -2.6% | 0.58% | +44.5% |
| Q1 2020 | $1,177,000 | -4.4% | 51,100 | +21.5% | 0.40% | +13.3% |
| Q4 2019 | $1,231,000 | +9.6% | 42,051 | 0.0% | 0.35% | +1.1% |
| Q3 2019 | $1,123,000 | -0.3% | 42,051 | -4.6% | 0.35% | -2.2% |
| Q2 2019 | $1,126,000 | +3.7% | 44,064 | -9.0% | 0.36% | -0.3% |
| Q1 2019 | $1,086,000 | +1.5% | 48,439 | -4.5% | 0.36% | -7.5% |
| Q4 2018 | $1,070,000 | +6.5% | 50,719 | -6.6% | 0.39% | +23.2% |
| Q3 2018 | $1,005,000 | -20.9% | 54,288 | -4.6% | 0.31% | -24.7% |
| Q2 2018 | $1,270,000 | +1.8% | 56,913 | +0.2% | 0.42% | +7.8% |
| Q1 2018 | $1,248,000 | -7.2% | 56,785 | -1.9% | 0.39% | -13.6% |
| Q4 2017 | $1,345,000 | +8.9% | 57,856 | +7.6% | 0.45% | +3.9% |
| Q3 2017 | $1,235,000 | -6.5% | 53,788 | -10.1% | 0.43% | -11.7% |
| Q2 2017 | $1,321,000 | +8.1% | 59,843 | +11.7% | 0.49% | -0.2% |
| Q1 2017 | $1,222,000 | -99.9% | 53,588 | +16.2% | 0.49% | +17.3% |
| Q4 2016 | $964,948,000 | +122666.9% | 46,126 | +55.2% | 0.42% | +14.2% |
| Q3 2016 | $786,000 | – | 29,729 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |